Advisornet Financial’s AtriCure ATRC Stock Holding History

Advisornet Financial’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3	Closed	-$133	–	2397
2022 Q4	$133	Buy	+3	New	+$125	﹤0.01%	2260

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Advisornet Financial's ATRC Position: Q1 2023 in Review

Advisornet Financial sold out of AtriCure (ATRC) in Q1 2023, closing a stake of 3 shares — an estimated $133 sold.

Advisornet Financial first reported a position in ATRC in Q4 2022 and held it in 1 quarter. The position peaked at $133 in Q4 2022. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2023.

Advisornet Financial reported no remaining AtriCure position as of Q1 2023 after selling out during the quarter.
Advisornet Financial sold 3 AtriCure shares in Q1 2023, an estimated $133.
Advisornet Financial first reported a position in AtriCure in Q4 2022 and held it in 1 quarter.
Advisornet Financial's AtriCure position peaked at $133 in Q4 2022.
224 funds tracked by Wall St. Rank held AtriCure as of Q1 2023.

Based on Advisornet Financial's 13F filing for Q1 2023, filed 28 Apr 2023.